In an April 1 report, Roth Capital Markets analyst Scott Searle maintained his “Buy” rating and $180.00 target on Universal Display Corporation (Universal Display Corporation Stock Quote, Chart, News, Analysts, Financials NASDAQ:OLED), saying concerns around smartphones, memory, macro risk and delayed blue emitter commercialization appear more than reflected in the stock. Searle said sentiment has […]
In a March 31 report, Research Capital analyst Andre Uddin maintained his “Speculative Buy” rating and US$5.50 target on NervGen Pharma (NervGen Pharma Stock Quote, Chart, News, Analysts, Financials NASDAQ:NGEN), saying the firm remains focused primarily on the company’s clinical progress rather than near-term financial results. Uddin said NervGen recently completed its end-of-Phase 2 meeting […]
Share
Tweet
Share
